Comparison of gradient diffusion and molecular methods using Allplex™ NG&DR assay (Seegene®) for macrolide and fluoroquinolone screening resistance in Neisseria gonorrhoeae
European Journal of Clinical Microbiology & Infectious Diseases · 2024
DOI: 10.1007/s10096-024-04786-y ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, 2024. Verfasst von Alfredo Maldonado-Barrueco und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Microbiology Department, Hospital Universitario La Paz, 261, Madrid, 28046, Spain. alfredo.maldonado@salud.madrid.org. Hauptthemen laut MEDLINE: Fluoroquinolones, Neisseria gonorrhoeae, Macrolides, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
Antimicrobial resistance in Neisseria gonorrhoeae (NG) is increasing worldwide. Second-line treatments with macrolides or fluoroquinolones are an option for NG infections in some cases following the STI guideline recommendations. In our study, we compared the gradient diffusion test using EUCAST 2024 breakpoints with a new molecular method using the Allplex™ NG&DR assay (Seegene®) including A2059G/C2611 mutations (23S rRNA) associated with high/moderate-level macrolide resistance and S91F mutation (gyrA) relationship with fluoroquinolone resistance in NG isolates (n = 100). We calculated the sensitivity, specificity, and correlation of the molecular test for fluoroquinolone using the gradient diffusion as the reference method. In twenty-three strains was not detected any mutation associated with macrolides or fluoroquinolone resistance. No A2059G/C2611T mutations were detected, and the S91F mutations were detected in 77 out of the 100 isolates screened. Twenty-three NG isolates were reported to be resistant to azithromycin (ECOFF: >1 mg/L), and 78 NG isolates were resistant to ciprofloxacin (MIC: >0.06 mg/L). The molecular method showed a sensitivity of 96.1% and, a specificity of 90.9% for fluoroquinolone susceptibility, but the statistical analysis between the molecular test and gradient diffusion test was not statistically significant for fluoroquinolone resistance (p = 1). Statistical analysis was not performed for macrolides because of the absence of positive RT-PCR results. According to our data, Allplex™ assay cannot replace the gradient diffusion test for macrolide resistance. However, the assay could be used to test fluoroquinolone resistance in NG isolates as a replacement for phenotypic methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Microbiology Department, Hospital Universitario La Paz, 261, Madrid, 28046, Spain. alfredo.maldonado@salud.madrid.org.
- Clinical Microbiology Department, Hospital Universitario La Paz, 261, Madrid, 28046, Spain.
- CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.
Zitieren
APA
Maldonado-Barrueco, A., Sanz-González, C., Falces-Romero, I., García-Clemente, P., Cacho-Calvo, J., & Quiles-Melero, I. (2024). Comparison of gradient diffusion and molecular methods using Allplex™ NG&DR assay (Seegene®) for macrolide and fluoroquinolone screening resistance in Neisseria gonorrhoeae. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-024-04786-y
Vancouver
Maldonado-Barrueco A, Sanz-González C, Falces-Romero I, García-Clemente P, Cacho-Calvo J, Quiles-Melero I. Comparison of gradient diffusion and molecular methods using Allplex™ NG&DR assay (Seegene®) for macrolide and fluoroquinolone screening resistance in Neisseria gonorrhoeae. European Journal of Clinical Microbiology & Infectious Diseases. 2024. doi:10.1007/s10096-024-04786-y
BibTeX
@article{MaldonadoBarrueco2024,
author = {Maldonado-Barrueco, Alfredo and Sanz-González, Claudia and Falces-Romero, Iker and García-Clemente, Paloma and Cacho-Calvo, Juana and Quiles-Melero, Inmaculada},
title = {Comparison of gradient diffusion and molecular methods using Allplex™ NG&DR assay (Seegene®) for macrolide and fluoroquinolone screening resistance in Neisseria gonorrhoeae},
journal = {European Journal of Clinical Microbiology & Infectious Diseases},
year = {2024},
doi = {10.1007/s10096-024-04786-y}
}
EUVIMED